1155 related articles for article (PubMed ID: 24438970)
21. Risk of progression of early-stage mycosis fungoides, 10-year experience.
Ariza Gómez SA; Dubeibe Abril PA; Niebles Sincelejo OE; Reina HSL
An Bras Dermatol; 2024; 99(3):407-413. PubMed ID: 38395632
[TBL] [Abstract][Full Text] [Related]
22. Extracorporeal photopheresis--a new approach for the treatment of cutaneous T cell lymphomas.
Gollnick HP; Owsianowski M; Ramaker J; Chun SC; Orfanos CE
Recent Results Cancer Res; 1995; 139():409-15. PubMed ID: 7597308
[TBL] [Abstract][Full Text] [Related]
23. Cost-utility analysis of mogamulizumab in advanced mycosis fungoides and Sézary syndrome cutaneous T-cell lymphoma.
Muszbek N; Remak E; Xin Q; McNamara L; Jones T
J Comp Eff Res; 2023 Jul; 12(7):CER. PubMed ID: 37338181
[No Abstract] [Full Text] [Related]
24. Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome.
Geskin LJ; Akilov OE; Kwon S; Schowalter M; Watkins S; Whiteside TL; Butterfield LH; Falo LD
Cancer Immunol Immunother; 2018 Mar; 67(3):423-434. PubMed ID: 29204699
[TBL] [Abstract][Full Text] [Related]
25. Extracorporeal Photopheresis in Dermatological Diseases.
Terhaar H; Saleem M; Yusuf N
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474257
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous malignancies and metastatic squamous cell carcinoma following topical therapies for mycosis fungoides.
Abel EA; Sendagorta E; Hoppe RT
J Am Acad Dermatol; 1986 Jun; 14(6):1029-38. PubMed ID: 3722479
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous T-cell lymphomas. A review of the recent literature.
Zackheim HS
Arch Dermatol; 1981 May; 117(5):295-304. PubMed ID: 6971626
[TBL] [Abstract][Full Text] [Related]
28. An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphoma.
Hu M; Scheffel J; Elieh-Ali-Komi D; Maurer M; Hawro T; Metz M
Clin Exp Med; 2023 Dec; 23(8):4177-4197. PubMed ID: 37555911
[TBL] [Abstract][Full Text] [Related]
29. Photochemotherapy in cutaneous T cell lymphoma and parapsoriasis en plaques. Long-term follow-up in forty-three patients.
Rosenbaum MM; Roenigk HH; Caro WA; Esker A
J Am Acad Dermatol; 1985 Oct; 13(4):613-22. PubMed ID: 3878369
[TBL] [Abstract][Full Text] [Related]
30. Mycosis fungoides: an overview.
Patel SP; Holtermann OA
J Surg Oncol; 1983 Apr; 22(4):221-7. PubMed ID: 6834842
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
Edelson RL
J Am Acad Dermatol; 1980 Feb; 2(2):89-106. PubMed ID: 6988470
[TBL] [Abstract][Full Text] [Related]
32. Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome.
Kohn EC; Steis RG; Sausville EA; Veach SR; Stocker JL; Phelps R; Franco S; Longo DL; Bunn PA; Ihde DC
J Clin Oncol; 1990 Jan; 8(1):155-60. PubMed ID: 2295906
[TBL] [Abstract][Full Text] [Related]
33. International symposium on cutaneous T cell lymphoma. Chicago, Illinois, Oct. 19-21, 1989.
Springer EA; Kuzel TM; Rosen ST; Roenigk HH
J Am Acad Dermatol; 1991 Jan; 24(1):136-8. PubMed ID: 1999510
[No Abstract] [Full Text] [Related]
34. Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.
Quaglino P; Prince HM; Cowan R; Vermeer M; Papadavid E; Bagot M; Servitjie O; Berti E; Guenova E; Stadler R; Querfeld C; Busschots AM; Hodak E; Patsatsi A; Sanches J; Maule M; Yoo J; Kevin M; Fava P; Ribero S; Zocchi L; Rubatto M; Fierro MT; Wehkamp U; Marshalko M; Mitteldorf C; Akilov O; Ortiz-Romero P; Estrach T; Vakeva L; Enz PA; Wobser M; Bayne M; Jonak C; Rubeta M; Forbes A; Bates A; Battistella M; Amel-Kashipaz R; Vydianath B; Combalia A; Georgiou E; Hauben E; Hong EK; Jost M; Knobler R; Amitay-Laish I; Miyashiro D; Cury-Martins J; Martinez X; Muniesa C; Prag-Naveh H; Stratigos A; Nikolaou V; Quint K; Ram-Wolff C; Rieger K; Stranzenbach R; Szepesi Á; Alberti-Violetti S; Felicity E; Cerroni L; Kempf W; Whittaker S; Willemze R; Kim Y; Scarisbrick JJ
Br J Dermatol; 2021 Apr; 184(4):722-730. PubMed ID: 32479678
[TBL] [Abstract][Full Text] [Related]
35. Tumor stage mycosis fungoides in a patient treated with long-term corticosteroids for asthma and atopic-like dermatitis.
Abel EA; Nickoloff BJ; Shelby DM; Watson W; Wood GS
J Dermatol Surg Oncol; 1986 Oct; 12(10):1089-93. PubMed ID: 3489744
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic and immunologic features associated with transformation of mycosis fungoides to large-cell lymphoma.
Cerroni L; Rieger E; Hödl S; Kerl H
Am J Surg Pathol; 1992 Jun; 16(6):543-52. PubMed ID: 1599034
[TBL] [Abstract][Full Text] [Related]
37. Combined total body X-ray irradiation and total skin electron beam radiotherapy with an improved technique for mycosis fungoides.
Halberg FE; Fu KK; Weaver KA; Zackheim HS; Epstein EH; Wintroub BU
Int J Radiat Oncol Biol Phys; 1989 Aug; 17(2):427-32. PubMed ID: 2666369
[TBL] [Abstract][Full Text] [Related]
38. Early diagnosis of mycosis fungoides and Sézary's syndrome by morphometric analysis of lymphoid cells in the skin.
Meijer CJ; van der Loo EM; van Vloten WA; van der Velde EA; Scheffer E; Cornelisse CJ
Cancer; 1980 Jun; 45(11):2864-71. PubMed ID: 6966534
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous T-cell lymphoma: a review.
Winkler CF; Bunn PA
Crit Rev Oncol Hematol; 1983; 1(1):49-92. PubMed ID: 6083835
[TBL] [Abstract][Full Text] [Related]
40. Histologic assessment of lymph nodes in mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification system.
Sausville EA; Worsham GF; Matthews MJ; Makuch RW; Fischmann AB; Schechter GP; Gazdar AF; Bunn PA
Hum Pathol; 1985 Nov; 16(11):1098-109. PubMed ID: 3876976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
